Biomedical subjects

T Aktunç

Publications and source records attributed to T Aktunç.

4 recordsLinked to original sources

PubMed1996

Centration of excimer laser photorefractive keratectomy and changes in astigmatism.

One of the most important factors that influence the success of PRK might be corneal centration during treatment. We evaluated our centration rate in 49 eyes by using computer-assisted corneal topography. Only single zone treated eyes were chosen for the analysis and 91.5% of the eyes were centered within a 1 mm treatment zone while 51% were within 0.5 mm. At the end of the follow-up time of 10.4 months, these centration zones were found to have no influence on the attempted spherical refractive outcome, whereas increasing decentration induced an increase in postoperative astigmatism.

Adult↗

PubMed1996

Double zone PRK for high myopia.

INTRODUCTION: Although excimer laser PRK is our operation of choice for treating myopia, the correction of myopia exceeding -8.00 dpt is still a challenge as this procedure requires a deeper keratectomy. Therefore a double zone treatment may be beneficial to reduce ablation depth. METHODS: Twenty-one eyes with myopia between -8.00 dpt and -14.00 dpt were included in this study. Twelve eyes were treated 60% of myopia by 5 mm zone and the remaining 40% in a 4 mm zone in the same session (Group 1). RESULTS: Nine eyes achieved 60% of the desired correction treated with a 4 mm zone whereas 40% correction was achieved in a 5 mm zone (Group 2). No significant difference in postoperative healing, pain, hyperopic shift, myopic regression and haze was observed at the end of the mean follow-up time (10.4 months) but photophobic complaints were less in Group 2. Best corrected visual acuity did not decrease significantly. CONCLUSIONS: Double zone treatment seems to be an interesting method for treating moderate to high myopia.

Adult↗

PubMed1992

Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial.

A single masked trial of cyclosporin A 5 mg/kg/day versus monthly 1 g intravenous boluses of cyclophosphamide was conducted among 23 patients with Behçet's syndrome and active, potentially reversible uveitis. The trial was unmasked after a mean of 12 (SD 2) months for the cyclosporin A group (n = 12) and a mean of 10 (SD 3) months for the cyclophosphamide group (n = 11). During the initial 6 months the visual acuity significantly improved (p < 0.001) in the cyclosporin A group whereas this was not observed in the cyclophosphamide group. The subsequent follow-up of patients up to 24 months suggested that the initial improvement in visual acuity with cyclosporin A was not sustained. More extensive and especially long-term studies of cyclosporin A in the uveitis of Behçet's syndrome are warranted.

Adolescent↗

PubMedDate not supplied

Simultaneous and sequential photorefractive keratectomy.

The purpose of this study was to show the safety, effectiveness, and predictability of simultaneous bilateral as compared to sequential unilateral photorefractive keratectomy in 273 normally sighted myopic eyes. An excimer laser with a fluence of 180 mj/cm2 at a frequency of 10 Hz was used at three ablation zones (5 mm, 6 mm, and 6.5 mm). There were no significant differences between the two groups' results. Mean refraction at six months was 0.34-0.96 D in group 1 simultaneous group and 0.32-0.95 D in group 2 sequential group. At 9 months after surgery, 84% of eyes had an uncorrected visual acuity of at least 20/40. The average pain score on the first postoperative day was 2.4 for group 1 simultaneous group and 2.3 for group 2 sequential group. No serious complications occurred. Despite the short follow up, simultaneous bilateral photorefractive keratectomy appears to be an effective and safe procedure for the correction of myopia.

Adult↗